- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03310606
Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis (SPAC)
Serum and Peritoneal Concentration in Antibiotics During the Surgical Management of Peritonitis: SPAC
SPAC is a pilote monocentric prospective study about peritonitis and antibiotics pharmacokinetic and pharmacodynamic. The investigators will included 50 patients during 2 years in the University Hospital of Nancy.
The aim of this study is to determine if the beta-lactam dosages recommended by the guidelines for management of intra-abdominal infections (published by the Société française d'anesthésie et de réanimation (Sfar) in december 2015) permitted the achievement of adequatly serum and peritoneal concentrations in the medical and surgical management of peritonitis.
The investigators will collected 3 pairs of serum and peritoneal fluid samples at 3 different times: peritoneal incision, arrival in ICU and 24 hours after admission in ICU in order to compare the concentrations and the minimal inhibitor concentration of bacteria.
The hypothesis is that of a serum and peritoneal antibiotic under dosage.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Phase
- Not Applicable
Contacts and Locations
Study Contact
- Name: Emmanuel NOVY, MD
- Phone Number: +33 3157437
- Email: e.novy@chru-nancy.fr
Study Contact Backup
- Name: El Mehdi SIAGHY
- Phone Number: +33 3155276
- Email: m.siaghy@chru-nancy.fr
Study Locations
-
-
-
Vandoeuvre les Nancy, France, 54500
- Recruiting
- Central Hospital
-
Contact:
- Emmanuel NOVY, MD
- Phone Number: +33 383157437
- Email: e.novy@chru-nancy.fr
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Minimun age limits 18 years
- All sex
- Patients with peritonitis (community or nosocomial) regardless of pathology involved
- Patients treated in the Universty Hospital of Vandoeuvre les Nancy (abdominal surgery unit and surgical Intensive care unit JM Picard)
Exclusion Criteria:
- Beta lactam allergy
- Pregnancy
- Age less than 18 years
- No respect of recommandations for antibiotics ( molecule and dosage)
- Person under legal protection
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Other: Peritonitis
Patient received for antibiotic treatment a B lactam according to French recommendation :
|
Dosage of serum and peritoneal of the B lactam used B lactam concerning are : CEFTRIAXONE, CEFOTAXIME, PIPERACILLINE/TAZOBACTAM, IMIPENEM
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Serum and peritoneal beta lactams concentrations at 3 times
Time Frame: 3 times : Peritoneal incision, Admission in ICU and 24 hours after admission in ICU
|
Population : patients with surgical peritonitis.
The concentrations are compared with the minimum inhibitory concentrations of bacteria to diagnose a sub therapeutic dosage.
|
3 times : Peritoneal incision, Admission in ICU and 24 hours after admission in ICU
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Factors associated with an antibiotic under-dosage
Time Frame: Statistical analysis after 2 years of inclusion
|
effect of presence of septic shock on antibiotic concentration
|
Statistical analysis after 2 years of inclusion
|
Factors associated with an antibiotic under-dosage
Time Frame: Statistical analysis after 2 years of inclusion
|
effect of volume ressucitation on antibiotic concentration
|
Statistical analysis after 2 years of inclusion
|
Factors associated with an antibiotic under-dosage
Time Frame: Statistical analysis after 2 years of inclusion
|
effect of renal function on antibiotic concentration
|
Statistical analysis after 2 years of inclusion
|
Evaluate the relationship between serum and peritoneal concentrations of beta-lactam
Time Frame: Statistical analysis after 2 years of inclusion
|
Determination of the antibiotic diffusion coefficient through the peritoneal membrane : difference between serum concentration and peritoneal concentration of B lactam
|
Statistical analysis after 2 years of inclusion
|
Morbidity of included patients
Time Frame: Reception on the 8th postoperative day
|
Morbidity is assessed by the presence or absence of second peritonitis surgery during hospitalization in ICU and at most 8 days (the mean of the peritonitis stays in the ICU of the investigators in 2016 is 8 days)
|
Reception on the 8th postoperative day
|
Mortality of included patients
Time Frame: Reception on the 8th postoperative day
|
The mortality is evaluated by the presence or absence of the death of the patient during the hospitalization in ICU and at most 8 days
|
Reception on the 8th postoperative day
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Emmanuel NOVY, MD, CHRU Nancy
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2017-A00710-53
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Critical Illness
-
Duke UniversityNational Institute of Neurological Disorders and Stroke (NINDS); National Institutes...CompletedNeonatal Critical Illness | Pediatric Critical IllnessUnited States
-
Yale UniversityNational Institute on Aging (NIA)RecruitingCritical Illness | Illness, CriticalUnited States
-
McMaster UniversityLondon Health Sciences Centre; McMaster Children's Hospital; Canadian Critical...CompletedPediatric Critical IllnessCanada
-
Boston Children's HospitalCompleted
-
St Helens & Knowsley Teaching Hospitals NHS TrustManchester University NHS Foundation TrustCompleted
-
Sándor BeniczkyUniversity of Aarhus; Danish Council for Independent Research; Søster og Verner...CompletedCritical Illness Myopathy | Myopathy Critical IllnessDenmark
-
Hospital de Clinicas de Porto AlegreUnknownCritical Illness PolyneuropathiesBrazil
-
Peking Union Medical College HospitalBaxter Healthcare CorporationUnknownNutrition Therapy for Critical Illness
-
Assistance Publique - Hôpitaux de ParisRecruitingCritical Illness Related Corticosteroids InsufficiencyFrance
-
Yuzuncu Yıl UniversityKahramanmaras Sutcu Imam University; Izmir Ataturk Training and Research HospitalCompleted
Clinical Trials on Dosage of serum and peritoneal of the B lactam used for antibiotic treatment
-
Central Hospital, Nancy, FrancePAPE EliseNot yet recruitingAppendicitis | Peritonitis | Children, Only | Antibiotic Toxicity
-
Central Hospital, Nancy, FranceCompletedBariatric Surgery Candidate | Obese | Antibiotic ProphylaxisFrance
-
Memorial Sloan Kettering Cancer CenterCompletedMetastatic Brain CancerUnited States
-
Laval UniversityGROUPE DE RECHERCHE EN SANTÉ RESPIRATOIRE DE L'UNIVERSITÉ LAVAL (GESER)CompletedObstructive Sleep Apnea | Treatment Compliance | Automatic Positive Airway PressureCanada
-
Target PharmaSolutions, Inc.RecruitingLiver Diseases | Hepatitis B | HepatitisUnited States, Canada
-
Universidad Autonoma de Baja CaliforniaCompletedPost Operative PainMexico
-
Fundación Pública Andaluza para la gestión de la...Spanish Clinical Research Network - SCReN; Spanish Network for Research in...RecruitingEnterococcal BacteremiaSpain
-
Stanford UniversityPatient-Centered Outcomes Research InstituteCompletedInsomnia | Obstructive Sleep Apnea of Adult | Circadian Rhythm Sleep Disorder | Sleep Related Movement Disorders | Narcolepsy and Hypersomnia | ParasomniaUnited States
-
Instituto de Investigacion Sanitaria La FeSociedad Española de Neumología y Cirugía Torácica; Sociedad Valenciana de... and other collaboratorsRecruitingCommunity-acquired PneumoniaSpain
-
CHU de ReimsUnknownPancreatic ResectionFrance